BioAdaptives Inc (BDPT)

[powerbattles]

They have the same terms as before, 200K, which means that if the stock moves higher, share dilution will be reduced. However, if they announce another new round of financing next quarter, it won't be effective for the next 6 months. I'm only planning on sticking around here beyond the end of the year if the next earnings report meets my requirements. Furthermore, I also need to see how they execute their business plan, their performance with patents, the success of the spin-off, and any potential partnerships. Any of these news announcements could likely drive the stock up by hundreds of percent. Instead of grasping at straws, I've decided to wait for the news.